Biopharmaceutical advocacy and educational outreach.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2023 | BRAVO GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination (No Activity) |
— | |
| 2022 | BRAVO GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2022 | BRAVO GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2022 | BRAVO GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2022 | BRAVO GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | |
| 2022 | BRAVO GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2021 | BRAVO GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2021 | BRAVO GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2021 | BRAVO GROUP |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| BRAVO GROUP | 9 | — |
| Issue | Activities |
|---|---|
| Medical/Disease Research/Clinical Labs | 7 |
| Health Issues | 7 |
| Medicare/Medicaid | 7 |